[144] Abeona Therapeutics Inc. SEC Filing

Rhea-AI Filing Summary

Abeona Therapeutics (ABEO) Form 144: This notice shows an intended sale of 15,000 shares of common stock through Stifel Nicolaus with an aggregate market value of $110,358, scheduled approximately for 08/15/2025. The filer acquired 47,303 shares as restricted stock units on 06/05/2024 and indicates cash payment on 06/06/2025. Recent disclosed sales by the same person total 64,708 shares for gross proceeds of $278,087.63 across trades on 06/06/2025, 07/09/2025, and 07/22/2025.

The form is a routine Section 144 notice required for proposed sales by an affiliate and includes the filer’s representation that no undisclosed material adverse information is known. The shares to be sold represent a small fraction of the issuer’s reported 51,278,539 outstanding shares.

Positive

• Compliance and transparency: The filer provided required broker, acquisition and sale details in a live Form 144 filing.

Negative

• Insider sales activity: The filer sold 64,708 shares in the past three months and proposes to sell an additional 15,000 shares, which may be perceived negatively by some investors.

Insights

Financial Analyst

TL;DR: Insider sales disclosed: routine Section 144 filing showing modest ongoing dispositions relative to total shares outstanding.

The filing reports a planned sale of 15,000 shares and prior sales totaling 64,708 shares producing $278,087.63 in proceeds. Relative to 51,278,539 shares outstanding, these transactions amount to roughly 0.13% of the float, suggesting limited direct dilution or corporate impact. The disclosure of acquisition as restricted stock units and subsequent cash payment is consistent with typical post-vesting liquidity actions by insiders. Investors should note the pattern of serial sales but the absolute scale appears immaterial to company capital structure based on the numbers provided in this filing.

Corporate Governance Expert

TL;DR: Filing meets disclosure obligations; the insider affirms no undisclosed material information but does not indicate a 10b5-1 plan.

The Form 144 provides required broker, transaction and acquisition details and includes the signed representation regarding material information. The document does not state adoption of a trading plan or provide a plan adoption date. The pattern of sales (06/06, 07/09, 07/22/2025 and proposed 08/15/2025) reflects active post-vesting sales of RSUs. From a governance standpoint, the filing is compliant and transparent; absence of an explicit 10b5-1 declaration in this notice is a neutral governance signal based solely on the content presented.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	15000	110358.00	51278539	08/15/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/05/2024	Restricted Stock Units	Issuer			47303	06/06/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Joseph Vazzano 6555 Carnegie Ave Fl 4 Cleveland OH 44103	Common Stock	07/22/2025	1502	9974.63
Joseph Vazzano 6555 Carnegie Ave Fl 4 Cleveland OH 44103	Common Stock	07/09/2025	25411	148799.00
Joseph Vazzano 6555 Carnegie Ave Fl 4 Cleveland OH 44103	Common Stock	06/06/2025	17795	120314.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ABEO Form 144 disclose?

The filing discloses a proposed sale of 15,000 common shares (aggregate value $110,358) and prior sales of 64,708 shares for $278,087.63.

Who is selling ABEO shares according to the filing?

The seller named in the prior sales is Joseph Vazzano and the proposed sale is to be handled by Stifel Nicolaus & Company Inc.

When were the acquired shares received and how were they acquired?

The shares to be sold were acquired as Restricted Stock Units on 06/05/2024, with 47,303 units listed and payment recorded as cash on 06/06/2025.

What is the approximate date for the proposed sale and on which exchange?

The proposed sale is approximately 08/15/2025 on Nasdaq via Stifel Nicolaus.

How large are these sales relative to ABEO’s outstanding shares?

The filing states 51,278,539 shares outstanding; the proposed 15,000-share sale is a small fraction (~0.03%) of outstanding shares.